Xuefei Ma

Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy.

H. Kuang, Xinyang Yu, M. Hao, 2019, European journal of pharmacology.

Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway

Xinyang Yu, M. Hao, H. Kuang, 2018, Gastroenterology research and practice.

Liraglutide alleviates H2O2-induced retinal ganglion cells injury by inhibiting autophagy through mitochondrial pathways

H. Kuang, M. Hao, Xinyuan Gao, 2017, Peptides.

Short‐term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity

H. Kuang, J. Pan, M. Hao, 2018, Andrologia.